Merve Keskinkilic | Medical Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Merve Keskinkilic | Medical Oncology | Best Researcher Award

Medical Oncologist, Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital Turkey

Merve Keskinkılıç is a dedicated Medical Oncologist at Burdur State Hospital with a strong academic background in Internal Medicine and Medical Oncology. She earned her M.D. from Dokuz Eylul University Faculty of Medicine and completed her Medical Oncology Fellowship at the same institution. Dr. Keskinkılıç has extensive clinical experience, having served as a Research Fellow at Emory University, USA. Fluent in English (C1 Advanced) and proficient in German (Elementary), she actively participates in international oncology research. Her expertise includes clinical trials, cancer treatment strategies, and translational oncology research, contributing significantly to advancements in the field.

Publication Profile

Scopus

Scholar

🎓 Education

Dr. Keskinkılıç completed her high school education at Balıkesir Science High School (2004-2008) before pursuing medicine at Dokuz Eylul University (2008-2014). She participated in an Oncology Exchange Program at Mansoura University, Egypt (2010). She later obtained an Associate Degree in Healthcare Management from Anadolu University (2014-2017). Her residency in Internal Medicine was completed at Celal Bayar University (2015-2016) and Dokuz Eylul University (2016-2019). She pursued a Medical Oncology Fellowship at Dokuz Eylul University (2019-2024) and is currently undertaking a PhD in Basic Oncology at Dokuz Eylul University Oncology Institute (since 2022). She also worked as a Research Fellow at Emory University, USA (2023).

💼 Experience

Dr. Keskinkılıç began her career as a General Practitioner at Balıkesir Susurluk State Hospital (2014-2015) before becoming a Research Assistant in Internal Medicine at Celal Bayar University (2015-2016) and later at Dokuz Eylul University (2016-2019). She served as a Specialist Doctor at Bitlis Mutki State Hospital (2019) and as a Fellow in Medical Oncology at Dokuz Eylul University (2019-2024). Currently, she is a Medical Oncologist at Burdur Public Hospital (2024-2025) and will join Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital in 2025.

🏆 Awards & Honors

Dr. Keskinkılıç holds several prestigious certifications, including the Turkish Board of Internal Medicine Certificate (2018), Experimental Animal Use Certificate (2019), Oncology Clinical Research Training Certificate (2020), and ESMO Board of Examination Certificate (2023). She has also completed Good Clinical Practices (ICU) and Clinical Research Training and has received certifications in Research Ethics and Clinical Trials. Her contributions to oncology research and education have been recognized through multiple national and international accolades.

🔬 Research Focus

Dr. Keskinkılıç specializes in clinical oncology research, focusing on urothelial, bladder, gastric, prostate, and lung cancers. She is actively involved in multiple clinical trials, serving as a Sub-Investigator in research projects such as THOR (Urothelial Cancer), Niagara (Bladder Cancer), MK3475-859 (Gastric Cancer), Regeneron (Non-Small Cell Lung Cancer), and Radiant 20510 (Prostate Cancer). Her work emphasizes innovative treatment strategies, immunotherapy, and targeted cancer therapies, contributing to the development of advanced oncological treatments. Her internal medicine dissertation evaluated CMV DNA Antigenemia in Allogeneic Bone Marrow Transplant Patients.

Publication Top Notes

  • Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
    • Authors: C. Karacin, B. Oksuzoglu, A. Demirci, M. Keskinkılıç, et al.
    • Journal: BMC Cancer, 2023
    • Citations: 20

 

  • Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
    • Authors: S. Kahraman, E. Erul, M. Seyyar, O. Gumusay, et al.
    • Journal: Future Oncology, 2023
    • Citations: 13

 

  • Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: a multicenter study
    • Authors: H. Ç. Yıldırım, E. Mutlu, E. Chalabiyev, M. Özen, et al.
    • Journal: The Breast, 2022
    • Citations: 13

 

  • The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor-positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and…
    • Authors: E. C. Yildirim, E. Atag, E. Coban, et al.
    • Journal: The Breast, 2023
    • Citations: 12

 

  • Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia
    • Authors: H. C. Yildirim, C. Kapar, B. Koksal, et al.
    • Journal: Journal of Chemotherapy, 2024
    • Citations: 4

 

  • The prognostic indicator in breast cancer treated with CDK4/6 inhibitors: the prognostic nutritional index
    • Authors: M. Keskinkilic, H. S. Semiz, G. Polat, et al.
    • Journal: Future Oncology, 2023
    • Citations: 4

 

  • Antibody-Drug Conjugates in Triple Negative Breast Cancer
    • Authors: M. Keskinkilic, R. Sacks
    • Journal: Clinical Breast Cancer, 2024
    • Citations: 3

 

  • 194P Increased blood creatinine level due to CDK 4/6 inhibitor treatments: single center experience
    • Authors: M. Keskinkılıç, H. S. Semiz, T. Yavuzsen, A. Karaoglu
    • Journal: Annals of Oncology, 2022
    • Citations: 3

 

  • The prognostic nutritional index (PNI): A new biomarker for determining prognosis in metastatic castration-sensitive prostate carcinoma
    • Authors: H. I. Ellez, M. Keskinkilic, et al.
    • Journal: Journal of Clinical Medicine, 2023
    • Citations: 11

 

  • The role of immune checkpoint inhibition in triple-negative breast cancer
    • Authors: K. Tarekegn, M. Keskinkilic, T. J. Kristoff, S. T. Evans, K. Kalinsky
    • Journal: Expert Review of Anticancer Therapy, 2023
    • Citations: 10

 

  • The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer
    • Authors: M. Hizal, B. Bilgin, N. Paksoy, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2023
    • Citations: 5

 

  • CD47 (‘don’t eat me’ signal) expression levels and its relationship with clinicopathologic features in early‐stage prostate carcinoma
    • Authors: H. S. Semiz, Ü. Küçük, E. Kısa, M. Keskinkılıç, et al.
    • Journal: The Prostate, 2022
    • Citations: 5

 

  • A severe case of levothyroxine intoxication successfully treated in intensive care unit
    • Authors: Y. Savran, T. Mengi, M. Keskinkilic
    • Journal: Journal of Acute Disease, 2018
    • Citations: 11

 

 

Ashwani Patil | Cancer Biology | Best Scholar Award

Posted on by ScienceFather

Dr. Ashwani Patil | Cancer Biology | Best Scholar Award

Assistant Professor, Dr. D. Y. Patil Institute of Pharmaceutical Sciences & Research India

Dr. Ashwani Patil is a passionate pharmacologist specializing in neurological disorders and cancer research. He completed his Ph.D. in Pharmacology from the Institute of Chemical Technology (ICT), Mumbai, with a focus on preclinical drug development. His research at Bhabha Atomic Research Centre and NIRRH Mumbai deepened his expertise in molecular mechanisms underlying complex diseases. With hands-on experience in animal handling, molecular techniques, and pharmacological testing, he has contributed significantly to understanding disease pathology and potential therapeutic targets for cancer and neurological disorders.

Professional Profile 

Scopus

Scholar

🎓Education

Ph.D. in Pharmaceutical Tech. (Pharmacology), Institute Of Chemical Technology, Mumbai (2024). M. Pharmacy (Pharmacology), R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur (2018). Bachelor of Pharmacy, A.R.A College of Pharmacy, Dhule (2016)

💼Experience

Junior Research Fellow, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur (2018-2019). Research Scholar, Institute of Chemical Technology, Mumbai (2022-Present). Assistant Professor, Dr. D Y Patil Institute of Pharmaceutical Science and Research, Pune (2019-2020, 2024). Expertise in preclinical drug studies, rodent surgery, data analysis, and project planning.

🏆Award and Honor

DAE-ICT Fellowship, 2024. 1st Position in Poster Presentation, 7th International Conference on “Emerging Trends in Drug Development and Delivery” (2024). Research Excellence Award, GEU, Dehradun (2015). Best Paper Presentation Award, TriboIndia 2023, NIT Srinagar

🔬 Research Focus

Dr. Patil’s research spans preclinical drug development, focusing on neurological disorders and cancer. His work investigates therapeutic targets, pharmacodynamics, and the molecular mechanisms of disease pathology. Key areas of interest include rodent models, drug efficacy, safety profiles, and mitochondrial toxicity. His publications highlight cancer cell cytotoxicity and cardioprotective effects, contributing to the understanding of pharmacological agents in disease treatment.

Publications Top Noted

1. Title: Cardioprotective effect of CB1 receptor antagonist AM251 against β receptor-stimulated myocardial infarction via modulation of NF-kB signaling pathway in diabetic mice

Year: 2024
Authors: Pawar, H.D., Patil, Y., Patil, A., Ojha, S., Goyal, S.N.
Citation: Heliyon, 10(15), e35138
Citations: 0

2. Title: Mitochondria-targeted derivative of pterostilbene, a dietary phytoestrogen, exhibits superior cancer cell cytotoxicity via mitochondrial superoxide mediated induction of autophagy

Year: 2023
Authors: Ibrahim, M.K., Nandha, S.R., Patil, A.S., Sharma, D., Sandur, S.K.
Citation: Advances in Redox Research, 8, 100071
Citations: 1

3. Title: Mitochondriotropic Derivative of Ethyl Ferulate, a Dietary Phenylpropanoid, Exhibits Enhanced Cytotoxicity in Cancer Cells via Mitochondrial Superoxide-Mediated Activation of JNK and AKT Signalling

Year: 2023
Authors: Patil, A.S., Ibrahim, M.K., Sathaye, S., Sharma, D., Sandur, S.K.
Citation: Applied Biochemistry and Biotechnology, 195(3), 2057–2076
Citations: 2

4. Title: Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review

Year: 2020
Authors: Patil, A.S., Mahajan, U.B., Agrawal, Y.O., Sharma, C., Goyal, S.N.
Citation: Biomedicine and Pharmacotherapy, 132, 110889
Citations: 17

5. Title: Protective effect of omeprazole and lansoprazole on β-receptor stimulated myocardial infarction in Wistar rats

Year: 2019
Authors: Patil, A.S., Singh, A.D., Mahajan, U.B., Ojha, S., Goyal, S.N.
Citation: Molecular and Cellular Biochemistry, 456(1-2), 105–113
Citations: 17

 

Jessica Abene| Oncology| Best Researcher Award

Posted on by ScienceFather

Ms. Jessica Abene| Oncology| Best Researcher Award

Ms. University of Pennsylvania,  United States

Jessica Abene is a dedicated nursing professional with a passion for advancing healthcare through evidence-based research. She earned her Bachelor of Nursing Science (BSN) from the University of Pennsylvania in 2023 and is currently pursuing a Master’s in Statistics and Data Science, as well as a PhD. Jessica is deeply engaged in research focused on improving patient care, particularly in oncology and eating disorders. She is an author of several publications, including systematic reviews on chemotherapy toxicities, food insecurity, and binge eating. Her expertise extends to clinical trials and the development of innovative healthcare solutions, such as a smart swaddle for infants with neonatal abstinence syndrome. Jessica is committed to improving patient quality of life through her work as a graduate research assistant and peer reviewer.

Profile

Scopus

🎓 Education

University of Pennsylvania Bachelor of Nursing Science (BSN), 2023. Master of Statistics and Data Science, In Process. Doctor of Philosophy, In Process

💼 Experience

Graduate Research Assistant, University of Pennsylvania, 2021-Present Jessica leads research on diet interventions to alleviate chemotherapy toxicities, coordinates data for clinical trials, and manages a systematic review on food insecurity and binge eating. Peer Reviewer, European Journal of Oncology Nursing, 2024-Present Evaluates submissions for scientific rigor, providing feedback to improve clarity and validity. Penn Nursing Innovation Accelerator Awardee, 2022 Led a team to develop a smart swaddle for infants with neonatal abstinence syndrome, offering comfort and distress relief.

🏆 Awards & Honors

Best Review Paper, International Journal of Eating Disorders (2023) Recognized for outstanding scholarly work as an early career scholar. Rita and Alex Hillman Foundation Pilot Award ($5,000) Awarded for innovative healthcare research. Doctoral Student Organization Research Grant ($325) Provided funding to support academic research. Penn Nursing Innovation Accelerator Awardee ($2,500) Awarded for leading an innovation team developing a smart swaddle system. Eastern Nursing Research Society Annual Conference Abstract Presentation (2023) Presented impactful research findings.

🔬 Research Focus

Jessica’s research aims to improve patient outcomes through evidence-based interventions. She is particularly focused on the impact of diet on chemotherapy toxicities and quality of life, as well as the relationship between food insecurity and binge eating disorders. Additionally, she coordinates clinical trials and studies exploring the effects of lymphedema and fibrosis treatment. Her innovative work includes developing a smart swaddle system for infants with neonatal abstinence syndrome (NAS). Jessica’s research seeks to create practical solutions for complex health challenges and contribute to enhancing patient care in diverse clinical settings.

🏆Conclusion 

Jessica Abene’s combination of rigorous academic training, innovative research, and leadership in healthcare makes her a standout candidate for the Best Researcher Award. Her systematic reviews, dedication to improving patient quality of life, and groundbreaking work in the intersection of healthcare and technology reflect her potential to make significant contributions to the nursing field. Continuing to expand her research network and engaging more broadly with the community will further enhance her already impressive career trajectory.

Publication

  • Dietary Interventions for Alleviating Chemotherapy Toxicities in Patients with Cancer: A Systematic Review
    Year: 2024
    Authors: Abene, J. & Deng, J.
    Status: In process

 

  • Diet as an Adjunct Therapy in Reducing Chemotherapy Toxicities and Improving Patients’ Quality of Life: A Systematic Review and Meta-Analysis
    Year: 2024
    Authors: Abene, J., Tyburski, S., Kral, T. V. E., Quinn, R., & Deng, J.
    Journal: Nutrition and Cancer, 1–19
    DOI: 10.1080/01635581.2024.2437833

 

  • Food Insecurity and Binge Eating: A Systematic Review and Meta-Analysis
    Year: 2023
    Authors: Abene, J. A., Tong, J., Minuk, J., Lindenfeldar, G., Chen, Y., & Chao, A. M.
    Journal: The International Journal of Eating Disorders, 56(7), 1301–1322

 

  • Binge Eating Disorder and Eating Self-Efficacy in Adults Seeking Bariatric Surgery
    Year: 2022
    Authors: Chao, A. M., Abene, J., Allison, K. C., Pearl, R. L., Wadden, T. A., Williams, N. N., & Tronieri, J. S.
    Journal: Clinical Obesity, e12531
    DOI: 10.1111/cob.12531

 

  • The Importance of Student Nursing and Engineering Collaborations
    Year: 2022 (May 20)
    Authors: Leary, M., Abene, J.
    Journal: American Nurse

 

TANUMA MISTRY | CLINICAL ONCOLOGY | Best Researcher Award

Posted on by ScienceFather

Dr. TANUMA MISTRY | CLINICAL ONCOLOGY | Best Researcher Award

 

Ms at CHITTARANJAN NATIONAL CANCER INSTITUTE, India

Tanuma Mistry is a dedicated research fellow in the Department of Pathology and Cancer Screening at Chittaranjan National Cancer Institute, Kolkata, India. She holds a Master of Science in Zoology from the University of Calcutta, with extensive research experience in life sciences, specifically cancer research. Tanuma has received prestigious awards, including the SERB International Travel and CSIR-Foreign Travel Grant. She is a member of notable societies such as ESMO, ASCO, and AACR. Tanuma’s research focuses on molecular techniques and targeted therapeutics, contributing significantly to various high-impact publications in the field of oncology.

profile

Scopus

Academic Qualification:🎓

Master of Science (2016): M.Sc. in Zoology from University of Calcutta, Kolkata, India.  Marks obtained: 75.1%. Bachelor of Science (2013):
B.Sc. in Zoology from University of Calcutta (Vidyasagar College for Women), Kolkata, India. Marks obtained: 68%. Higher Secondary Examination (10+2): West Bengal Council of Higher Secondary Education (WBCHSE), Kolkata, India. Ariadaha Sarbamangala Balika Vidyalaya
Marks obtained (Best of 4): 70.75%. Secondary Examination (10): West Bengal Board of Secondary Education (WBBSE), Kolkata, India.
Ariadaha Sarbamangala Balika Vidyalaya Marks obtained: 71.75%

Other Qualification:🧬

CSIR NET-JRF (June 2018) in Life Science (AIR-118). West Bengal State Eligibility Test (WBSET) 2018 in Life Science The Graduate Aptitude Test in Engineering (GATE)-XL 2022 in Life Science

Awards:🏅

SERB International Travel: ESMO Asia Congress 2023, Singapore. CSIR-Foreign Travel Grant: EBCC-13; Barcelona, Spain. 13th East Zonal Oncology Symposium 2024: 2nd Position in Poster Presentation

Membership of Societies:

The Zoological Society, Kolkata,  European Society of Medical Oncology (ESMO) [Id: 561295], 🇺🇸 American Society of Clinical Oncology (ASCO) [Id: 7278374],  American Association for Cancer Research (AACR) [Id: 1304687]

Research Experience:🔬

2019 – Till Date: CSIR Research Fellow Department of Pathology & Cancer Screening, Chittaranjan National Cancer Institute
Registered under Jadavpur University, Department of Life Science and Biotechnology, Kolkata, India

Skills in Laboratory Techniques:

Molecular techniques: Isolation of DNA, RNA, and Protein, PCR, RFLP, RT-PCR, Electrophoresis, Immunohistochemistry, Western Blotting, Northern Blotting, Southern Blotting, DNA sequencing, MTT assay. Computational skills: Operating systems: Windows, Mac Software: Microsoft Office, Statistical Software Sigma Graph & Plot, GraphPad Prism, SPSS, Mendeley, EndNote

Review during M.Sc:

Behavioral Ecology and Conservation Strategies of Greater One-horned Rhinoceros (Rhinoceros unicornis):
Under the Supervision of Dr. Rakesh Tamang

Project during M.Sc:

Localized Survey of Two Important Bio-resources (TEA & FISH) Types and Practices at Dooars Region of North Bengal:
Under the Supervision of Dr. Sumit Homechoudhury

Publications Top Notes

  • Title: Emerging futuristic targeted therapeutics: A comprising study towards a new era for the management of TNBC
    Authors: Mistry T, Nath A, Pal R, Ghosh S, Sahoo PK, Mahata S, Sarkar S, Choudhury T, Nath P, Alam N, Nasare VD
    Year: 2024
  • Title: Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer
    Authors: Nath A, Mitra S, Mistry T, Pal R, Nasare VD
    Year: 2021
    Journal: Medical Oncology
    DOI: 10.1007/s12032-021-01610-x
  • Title: Mitotic checkpoint defects: en route to cancer and drug resistance
    Authors: Sarkar S, Sahoo PK, Mahata S, Pal R, Ghosh D, Mistry T, Ghosh S, Bera T, Nasare VD
    Year: 2021
  • Title: PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
    Authors: Mahata S, Sahoo PK, Pal R, Sarkar S, Mistry T, Ghosh S, Nasare VD
    Year: 2022
    Journal: Medical Oncology
  • Title: Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India
    Authors: Sarkar S, Sahoo PK, Pal R, Mistry T, Mahata S, Chatterjee P, Vernekar M, Mandal S, Bera T, Nasare VD
    Year: 2022
  • Title: Premalignant and malignant lesions of oral cavity in eastern India: a hospital-based study
    Authors: Sahoo PK, Sarkar S, Ghosh D, Mahata S, Pal R, Mistry T, Ghosh S, Roy A, Bucha H, Mandal S, Nasare VD
    Year: 2021
  • Title: Outcome of 3-year follow-up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study
    Authors: Sahoo PK, Bhowmick AK, Sarkar S, Mahata S, Pal R, Mistry T, Ghosh S, Choudhury T, Kumar RS, Mandal S, Datta S, Nath P, Mukherjee KK, Nasare VD
  • Title: Polymorphism of transporter genes contributes to variations in treatment outcomes and adverse events in platinum-based chemotherapy-treated oral cancer patients
    Authors: Sahoo PK, Mistry T, Sarkar S, Ghosh D, Mahata S, Pal R, Ghosh S, Roy A, Bucha H, Mandal S, Datta S, Nasare VD
    Year: 2024
  • Title: Impact of Low BMI and Nutritional Status on Quality of Life and Disease Outcome in Breast Cancer Patients: Insights from a Tertiary Cancer Center in India
    Authors: Mistry T, Pal R, Ghosh S, Choudhury T, Mandal S, Nath P, Alam N, Nasare VD
    Year: 2024

 

Divya Kumar | Clinical |Best Researcher Award

Posted on by ScienceFather

Dr. ‌Divya Kumar |Clinical| Best Researcher Award

Dr at McLean Hospital, United States

Divya Kumar is a dedicated clinical psychologist with a focus on affective disorders and behavioral interventions. Currently completing a Post-Doctoral Fellowship at McLean Hospital/Harvard Medical School, Divya’s research and clinical experiences span various settings, including academic institutions and healthcare facilities. With expertise in positive affect dysregulation and depression treatment, Divya has authored multiple peer-reviewed publications and presented at national conferences. Their commitment to teaching and mentorship is evident through roles as an instructor and teaching assistant. Divya’s comprehensive training and contributions to the field make them a valuable asset in clinical research and practice.

Profile

 

📚Education 

McLean Hospital/Harvard Medical School Belmont, MA Post-Doctoral Fellowship, Clinical Psychology July 2023 – Present Pre-Doctoral Intern, Clinical Psychology July 2022 – June 2023 Southern Methodist University Dallas, TX Doctoral Candidate, Clinical Psychology July 2023 Advisor: Alicia E. Meuret, Ph.D. Dissertation: A randomized controlled trial of brief behavioral activation plus savoring for positive emotion dysregulation in university students Master of Arts, Clinical Psychology August 2020 Advisor: Alicia E. Meuret, Ph.D. Thesis: Walking on the bright side: Associations between depression, affect, and gait Washington University in St. Louis St. Louis, MO Bachelor of Arts, Philosophy-Neuroscience-Psychology December 2014

Honours and awards 🏆

🏆 2024 Career Development Leadership Program Anxiety and Depression Association of America🎓 2017 – 2023 University Ph.D. Fellowship Award Southern Methodist University🏅 2022 Virginia Roswell Student Dissertation Award Association of Behavioral and Cognitive Therapies🔬 2019 President Partner’s Grant Southern Methodist University (CO-I: Alicia Meuret)🎖️ 2019 Honorable Mention for Graduate Research Fellowship Program National Science Foundation🥇 2019 Graduate Student Research Day Award Dedman College, Southern Methodist University

manuscripts in peer reviewed journals

Kumar, D., Corner, S., Kim, R., Meuret, A. (2024). A randomized controlled trial of brief behavioral activation plus savoring for positive affect dysregulation in university students. Behaviour Research and Therapy, 104525. Alvi, T., Kumar, D., Tabak, B. (2022). Social anxiety and behavioral assessments of social cognition: A systematic review. Journal of Affective Disorders, 311, 17-30. Kumar, D., Villarreal, D. J., Meuret, A. E. (2021). Walking on the bright side: Relations between depression, affect, and gait. PLoS one, 16(12), e0260893. Kumar, D., Tully, L.M., Iosif, A.M., Nye, K.E., Zakskorn, L.N., Zia, A., Niendam, T.A. (2018). A mobile health platform for clinical monitoring in early psychosis: implementation in community-based outpatient early psychosis care. Journal of Medical Internet Research Mental Health, 5(1): e15. Niendam, T.A., Tully, L.M., Iosif, A.M., Kumar, D., Burch, K., Denton, J., Zakskorn, L., Fedechko, T., Pierce, K. (2018). Enhancing early psychosis treatment using smartphone technology Part I: Feasibility and validity. Journal of Psychiatric Research, 96, 239-246.

Clinical Experience 🏥

Behavioral Health Partial Hospitalization Program, McLean Hospital Belmont, MA Psychology Intern | July 2022 – July 2023As a psychology intern, I provided brief intervention for patients in the partial hospital program, drawing skills from CBT, ACT, and DBT. Additionally, I led and co-led skills-based groups on empirically supported therapies weekly. Moreover, I provided individual ERP therapy through the McLean Obsessive Compulsive Disorder Institute as part of a 3-month rotation and individual psychotherapy through the McLean OnTrack Early Psychosis Clinic. 🩺Treatment for Affective Dimensions Study, Dallas, TX Study Therapist | August 2018 – June 2022In this role, I provided psychotherapy related to increasing positive affect through behavioral activation, positive cognitive strategies, and mindfulness practices. I also offered psychotherapy related to decreasing negative affect through inhibitory learning model exposures, cognitive restructuring, and respiratory biofeedback. Furthermore, I conducted structured diagnostic evaluations (SCID-5) for study intake. 🧠SMU Psychology Clinic, Dallas, TX
Advanced Practicum Student | June 2021 – June 2022At the SMU Psychology Clinic, I provided structured diagnostic interviews and individual psychotherapy via telehealth to adult clients in Dallas using empirically-supported treatments such as CBT, ACT, and CPT. Additionally, I conducted symptom-based evaluations of trauma in collaboration with the Human Rights Initiative of Dallas for individuals seeking legal citizenship through the U-VISA program and Violence Against Women Act. 💬Behavioral Activation plus Savoring Study, Dallas, TX
Principal Investigator/Study Therapist | July 2021 – June 2022In this position, I served as the principal study therapist, providing two sessions of brief behavioral activation plus savoring therapy for university students with low positive affect. I also created therapy manuals and homework assignments for a randomized controlled trial and trained master’s-level graduate students in delivering manualized treatment. 📚Veteran’s Association North Texas Health Care System, Dallas, TX Practicum Student | August 2020 – June 2021During my time here, I provided individual psychotherapy via Telehealth utilizing Acceptance and Commitment Therapy to Veterans for symptoms relating to depression, anxiety, and physical health. Additionally, I engaged in individual supervision to enhance competency in providing gender-affirming care. 🔍

Additional Clinical Training Experience and Workshops 🎓

In addition to my clinical experience, I’ve undertaken various training sessions and workshops to enhance my skills and knowledge in the field of psychology:

Positive Affect Treatment Training 🌟Inhibitory Exposure (Negative Affect Treatment Training) 🛑Psychological Assessment Series Training: Millon Multiaxial Clinical Inventory 📝Psychological Assessment Series Training: Personality Assessment Inventory 🧠Comprehensive Behavioral Intervention for Tics 💭Treatment for Affective Disorders 🌈Capnometry-Assisted Respiratory Training 💨Cognitive Processing Therapy for Post-Traumatic Stress Disorder 🧠Integrated Psychosis Assessment Training 🔄Structured Clinical Interview for DSM-5 (SCID-5) Training 💬Training in Applied Behavior Analysis for Children with Autism 🧩

 

Publications Top Notes 📝

 

  1. Enhancing Early Psychosis Treatment Using Smartphone Technology: A Longitudinal Feasibility and Validity Study
    • Journal: Journal of Psychiatric Research, 2018
    • Citations: 117
    • Authors: T.A. Niendam, L.M. Tully, A.M. Iosif, D. Kumar, K.E. Nye, J.C. Denton, …

 

  1. A Mobile Health Platform for Clinical Monitoring in Early Psychosis: Implementation in Community-based Outpatient Early Psychosis Care
    • Journal: JMIR Mental Health, 2018
    • Citations: 75
    • Authors: D. Kumar, L.M. Tully, A.M. Iosif, L.N. Zakskorn, K.E. Nye, A. Zia, T.A. Niendam

 

  1. Social Anxiety and Behavioral Assessments of Social Cognition: A Systematic Review
    • Journal: Journal of Affective Disorders, 2022
    • Citations: 23
    • Authors: T. Alvi, D. Kumar, B.A. Tabak

 

  1. Walking on the Bright Side: Associations Between Affect, Depression, and Gait
    • Journal: PLOS One, 2021
    • Citations: 7
    • Authors: D. Kumar, D.J. Villarreal, A.E. Meuret

 

  1. A Randomized Controlled Trial of Brief Behavioral Activation Plus Savoring for Positive Affect Dysregulation in University Students
    • Journal: Behaviour Research and Therapy, 2024
    • Authors: D. Kumar, S. Corner, R. Kim, A. Meuret